• Home
  • Events
  • Duke SOM: Investigational Device Exemption Workshop
Month Flat Week Day
Date: Friday, February 17, 2023 12:00 pm - 2:00 pm
Categories: Other Sponsor

Best Practices for the Preparation, Submission, and Maintenance of Sponsor-Investigator Investigational Device Exemptions (IDEs)

The Duke University School of Medicine Office of Regulatory Affairs and Quality is conducting an IDE Workshop.

This workshop will:

  • Discuss FDA’s approach to regulation of devices in clinical studies and for marketing
  • Provide guidance on when the IDE regulations apply and discuss possible exemptions
  • Review significant risk and non-significant risk device studies
  • Discuss the preparation, submission, and maintenance of IDE applications
  • Encourage participant discussion of case scenarios

Speakers: Kylie Opel, JD and David Jensen, PhD, RAC

Register

NC TraCS Regulatory Support is available to provide guidance and assistance with IND and IDE submissions and understanding the regulatory requirements for Federally-regulated studies. UNC Investigators and study teams with questions about regulatory submissions and pathways can submit a request to speak with an expert.

See also: IND workshop February 10

Get NC TraCS events and news delivered to your inbox! Subscribe to our weekly email blast

Need help advertising your event? Contact Michelle Maclay at michelle_maclay@med.unc.edu

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact